By Shalini Bhardwaj
Gurugram (Haryana) [India], A private hospital in Gurugram on Thursday pioneered neurosurgical innovation and became the first facility in South Asia to introduce the latest Gamma Knife technology (Gamma Knife Esprit), which improves accuracy and effectiveness in treatment. Symbolizes a huge leap. Various neurological conditions.
The non-surgical technique ensures high success rates for controlling brain tumors and other brain conditions with minimal side effects and its radiosurgery boasts an impressive track record, with a control rate of more than 95 percent at 10 years, which Provides long term relief. The private hospital is identified as Fortis Memorial Research Institute (FMRI), located in Gurugram district, Haryana.
This groundbreaking version of the Leksel Gamma Knife® ushers in a new era in non-surgical, high-precision treatment of brain tumors, expanding therapeutic options for both malignant and benign brain tumors and other brain abnormalities.The Gamma Knife uses computer-guided precision to target brain tumors without actual cutting, making it an optimal choice for treating both malignant and benign tumors, including multiple brain metastases, meningiomas, acoustic tumors, and pituitary adenomas. Is. Its precision is important for tumors in sensitive or inaccessible brain areas, it spares healthy brain tissue and allows patients to return to daily activities almost immediately. According to Dr. Sandeep Vaish, Director of Neurosurgery, Fortis Gurugram, “Our The launch of South Asia's first Gamma Knife Esprit at the facility is a significant milestone in the field of neurosurgery. This advanced technology brings levels of precision to neurosurgical procedures that were previously unattainable, targeting brain tumors with pinpoint accuracy."
“Gamma Knife Esprit minimizes radiation exposure to healthy tissues which is important to minimize potential side effects.This capability allows us to significantly increase patient safety and comfort, thus optimizing the recovery process. By drastically reducing recovery times, we are not only improving clinical outcomes, but also enhancing the overall patient experience, a step in our ongoing effort to push the boundaries of what is possible in medical treatment and patient care Is."
Anil Vinayak, Group COO, Fortis Healthcare, elaborated on Fortis' comprehensive vision as a leader in comprehensive cancer care. “The deployment of the first Gamma Knife Esprit in South Asia to integrate cutting-edge technologies in neurosurgery and holistic cancer care is a testament to Fortis Healthcare's commitment to providing comprehensive care that enhances the overall patient journey and outcomes.This initiative is another step towards strengthening our position at the forefront of medical innovation and patient-centric care across the region,” Vinayak said.
Jan Thesleff, Ambassador of Sweden to India, who was the chief guest at the inauguration, said, “I am deeply honored to see the pioneering collaboration between Swedish companies like Electra and India's leading healthcare chain, Fortis Healthcare. This is a historical introduction." The technology, the first of its kind in South Asia, underlines the transformative impact of our partnership and fMRI's dedication to advancing healthcare excellence."
“Swedish companies are renowned for their leadership in healthcare innovation, and through initiatives like this, we are collectively closing the gap in advanced medical treatments, ensuring that patients in the region have access to cutting-edge care. yes.Our continued collaboration between Sweden and India, particularly with Fortis Healthcare, is a testament to our shared commitment to innovation and excellence in healthcare. I look forward to the continued success of our partnership and the delivery of sustainable healthcare solutions for all. "Furthermore, radiation therapy for multiple brain metastases requires approximately 30 sessions; in contrast, Gamma Knife radiosurgery consolidates the entire treatment into a single session with same-day discharge. Due to which the treatment becomes faster and efficient.
Additionally, the Gamma Knife can treat multiple metastases in a single session, regardless of the metastatic lesions involved, an advantage not provided by other technologies. This method significantly reduces radiation exposure to healthy tissues, preserving motor, sensory, neural and neurocognitive functions, enabling faster recovery and improving health quality of life after treatment . Thus, Gamma Knife radiosurgery is considered the gold standard for brain radiosurgery worldwide.The procedure can be performed using frame-based or frameless methods for personalized care of patients with a comfortable treatment experience and is followed by stereotactic MRI to ensure precise treatment delivery. Fortis Healthcare has introduced Gamma Knife technology , which is a time-tested, reliable method with wide clinical recognition and high confidence among physicians and patients in India and around the world.
This integrated and efficient system boasts a guaranteed accuracy of 0.3 mm, delivering doses to healthy brain tissue that are 2-4 times lower than other technologies, with 2-21 times lower extracranial doses.
This highest accuracy and precision of Gamma Knife minimizes toxicity and side effects in normal brain.
Gurugram (Haryana) [India], A private hospital in Gurugram on Thursday pioneered neurosurgical innovation and became the first facility in South Asia to introduce the latest Gamma Knife technology (Gamma Knife Esprit), which improves accuracy and effectiveness in treatment. Symbolizes a huge leap. Various neurological conditions.
The non-surgical technique ensures high success rates for controlling brain tumors and other brain conditions with minimal side effects and its radiosurgery boasts an impressive track record, with a control rate of more than 95 percent at 10 years, which Provides long term relief. The private hospital is identified as Fortis Memorial Research Institute (FMRI), located in Gurugram district, Haryana.
This groundbreaking version of the Leksel Gamma Knife® ushers in a new era in non-surgical, high-precision treatment of brain tumors, expanding therapeutic options for both malignant and benign brain tumors and other brain abnormalities.The Gamma Knife uses computer-guided precision to target brain tumors without actual cutting, making it an optimal choice for treating both malignant and benign tumors, including multiple brain metastases, meningiomas, acoustic tumors, and pituitary adenomas. Is. Its precision is important for tumors in sensitive or inaccessible brain areas, it spares healthy brain tissue and allows patients to return to daily activities almost immediately. According to Dr. Sandeep Vaish, Director of Neurosurgery, Fortis Gurugram, “Our The launch of South Asia's first Gamma Knife Esprit at the facility is a significant milestone in the field of neurosurgery. This advanced technology brings levels of precision to neurosurgical procedures that were previously unattainable, targeting brain tumors with pinpoint accuracy."
“Gamma Knife Esprit minimizes radiation exposure to healthy tissues which is important to minimize potential side effects.This capability allows us to significantly increase patient safety and comfort, thus optimizing the recovery process. By drastically reducing recovery times, we are not only improving clinical outcomes, but also enhancing the overall patient experience, a step in our ongoing effort to push the boundaries of what is possible in medical treatment and patient care Is."
Anil Vinayak, Group COO, Fortis Healthcare, elaborated on Fortis' comprehensive vision as a leader in comprehensive cancer care. “The deployment of the first Gamma Knife Esprit in South Asia to integrate cutting-edge technologies in neurosurgery and holistic cancer care is a testament to Fortis Healthcare's commitment to providing comprehensive care that enhances the overall patient journey and outcomes.This initiative is another step towards strengthening our position at the forefront of medical innovation and patient-centric care across the region,” Vinayak said.
Jan Thesleff, Ambassador of Sweden to India, who was the chief guest at the inauguration, said, “I am deeply honored to see the pioneering collaboration between Swedish companies like Electra and India's leading healthcare chain, Fortis Healthcare. This is a historical introduction." The technology, the first of its kind in South Asia, underlines the transformative impact of our partnership and fMRI's dedication to advancing healthcare excellence."
“Swedish companies are renowned for their leadership in healthcare innovation, and through initiatives like this, we are collectively closing the gap in advanced medical treatments, ensuring that patients in the region have access to cutting-edge care. yes.Our continued collaboration between Sweden and India, particularly with Fortis Healthcare, is a testament to our shared commitment to innovation and excellence in healthcare. I look forward to the continued success of our partnership and the delivery of sustainable healthcare solutions for all. "Furthermore, radiation therapy for multiple brain metastases requires approximately 30 sessions; in contrast, Gamma Knife radiosurgery consolidates the entire treatment into a single session with same-day discharge. Due to which the treatment becomes faster and efficient.
Additionally, the Gamma Knife can treat multiple metastases in a single session, regardless of the metastatic lesions involved, an advantage not provided by other technologies. This method significantly reduces radiation exposure to healthy tissues, preserving motor, sensory, neural and neurocognitive functions, enabling faster recovery and improving health quality of life after treatment . Thus, Gamma Knife radiosurgery is considered the gold standard for brain radiosurgery worldwide.The procedure can be performed using frame-based or frameless methods for personalized care of patients with a comfortable treatment experience and is followed by stereotactic MRI to ensure precise treatment delivery. Fortis Healthcare has introduced Gamma Knife technology , which is a time-tested, reliable method with wide clinical recognition and high confidence among physicians and patients in India and around the world.
This integrated and efficient system boasts a guaranteed accuracy of 0.3 mm, delivering doses to healthy brain tissue that are 2-4 times lower than other technologies, with 2-21 times lower extracranial doses.
This highest accuracy and precision of Gamma Knife minimizes toxicity and side effects in normal brain.
